Interdepartmental Pain Center, Department of Neurosurgery, University of Milano, Italy.
Int J Clin Exp Hypn. 2022 Jul-Sep;70(3):286-299. doi: 10.1080/00207144.2022.2094269. Epub 2022 Jul 6.
Increasing evidence suggests that the gut-brain axis may play a key role in health and disease via a bidirectional communication network involving neural and immunoendocrine pathways. This complex interplay deeply influences both gut microbiota and brain behavior. Pathobiome or gut dysbiosis is relevant for the pathogenesis of functional gastrointestinal disorders, such as IBS, chronic pain syndromes, and neurological and mental disorders. As a consequence, targeting the gut microbiota is emerging as a novel, effective therapeutic perspective. Among many treatment options, psychological interventions, including hypnosis, have been used to target the so-called psychobiome and its hypnotic analogue, i.e., hypnobiome, referring to their potential efficacy to modulate the mind-gut axis in IBS patients. A narrative review of the recent literature is provided and circumstantial evidence suggests that hypnobiome may represent a new promising frontier of hypnotherapy.
越来越多的证据表明，通过涉及神经和免疫内分泌途径的双向通讯网络，肠道-大脑轴可能在健康和疾病中发挥关键作用。这种复杂的相互作用深刻地影响了肠道微生物群和大脑行为。 病理生物群或肠道菌群失调与功能性胃肠疾病（例如 IBS、慢性疼痛综合征以及神经和精神疾病）的发病机制有关。 因此，针对肠道微生物群已成为一种新的有效治疗方法。 在许多治疗选择中，包括催眠在内的心理干预措施已被用于针对所谓的心理生物群及其催眠类似物（即，催眠生物群），这是指它们在调节 IBS 患者的“脑-肠轴”方面的潜在功效。 对最近文献的叙述性综述表明，催眠生物群可能代表了催眠治疗的一个新的有前途的前沿领域。
